“Despite a backlash to its recent crackdown on the sale of counterfeit medicines in Bangladesh’s capital, Dhaka, the government has vowed to continue fighting the growing industry of illicit, substandard, counterfeit and life-endangering medicines,” IRIN reports. The article describes a September government seizure of “fake, substandard and unauthorized medicine” in the country’s medicine market and other government efforts to evaluate pharmaceutical companies and prevent such medicines from reaching the market (11/4).